Tiburcio Mamani has a 17 years old daughter with a Brain Tumor. (more…)
Brain Tumor
Cancer remains the main use of Vilac Plus over the world since the publication of 3 clinical trials : Brain Tumor and Lung Cancer in 2006, then Cervical Cancer in 2007. The antiradical effectiveness of Vilac Plus had already been proved In Vitro (KRL Test).
Dr Wichit Kirdpon, Dr Kawee Tungsubutra, Khon Kaen University, Thailand
Khon Kaen University got a spectacular result: a desperate case of brain tumor was cured. This is unique in the world, and the first published scientific report about the effects of Vilac Plus® as an alternative therapy.
Two interviews in English, subtitled in Spanish :
- Dr. Wichit Kirdpon reports that Vilac Plus® is efficient for any degenerative disease, as well as diabetis, conjunctivitis, skin disease and allergies.
- Dr. Kawee Tungsubutra, President of Thailand Radiology Society, associates radiotherapy and chemotherapy with traditional medicine. Because its strengthens body and mind health, herbal medicine helps a lot.
Nicolas Lagoueyte talks (
in french) about the philosophy behind the world-wide commercialisation of Vilac Plus® products. (more…)
Dr. Pongsiri Prathnadi
This 15 minutes long interview was taken from a December 2006 movie by William Oroso.
Dr Pongsiri Prathnadi is shown in his office of the Department of Surgery, Faculty of Medicine, Chiang Mai University, Thailand.
He is the President of the Anti-Tuberculosis Association of Chiang Mai Province.
He also presides the Society of Gerontology in Thailand.
His team first experimented the Vilac Plus® herbal drink as an immune booster, for HIV, and then on patients with various advanced cancers.
He talks about their findings (effects on immunity and quality of life especialy), and about the clinical trial results on cancer stade IIIB & IV at Khon Kaen University. (more…)
Brain Tumor – Clinical Trials
Evaluation of the effectiveness of the product the Vilac Plus® Eubiotic Drink G716/45 on Cancers Stage IIIB and IV.
Palliative treatment of advanced subependymal oligodendroglioma with radiotherapy and Thai herbal medicine as supportive remedy
Clinical trials HE480745 conducted at Srinagarind Public Hospital, Faculty of Medicine, Khon Kaen University, Thailand. Published in The Asean Journal of Radiology, September – December 2006.
Abstract
Objective
To evaluate the supportive effect of Thai herbal medicine, Vilac Plus complementarity to standard palliative radiotherapy in comparison with historic control from the literature reports in subependymal oligodendrogliomas.
Method
An inoperable subependymal oligodendroglioma in a 14 years old boy being treated by palliative radiotherapy and concurrent with Thai herbal medicine (Vilac Plus) as supportive remedy.
Result
The result revealed complete response of advanced subependymal oligodendroglioma. The patient shows good quality of life until now, 43 months after the diagnosis and starting the treatment. In addition, there is also omprovement of diabetes insipidus and still alive with Karnofsky’s performance status 100%. Currently the follow-up time is 43 months after the initial diagnosis and treatment (craniotomy and tumor biopsy).
Conclusion
The results of radiotherapy of an inoperable subependymal oligodendrogrlioma using Thai herbal medicine as an adjuvant remedy has been very satisfactory with good quality of life. This combination modality of treatment present a very promising and cost effectiveness therapy, leading to the confirmation of the concept of complementary approaches on cancer therapy.